Heart Failure Therapy in Patients with Diabetes The new Benefit-Risk-Assessment of Sacubitril/Valsartan

Vincent Matthias Brandenburg^*, Hanspeter Brunner-La Rocca^*, Nikolaus Marx^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

4 Citations (Web of Science)

Original language	English
Pages (from-to)	1647-1649
Journal	Deutsche Medizinische Wochenschrift
Volume	141
Issue number	22
DOIs	https://doi.org/10.1055/s-0042-000001
Publication status	Published - Oct 2016

Access to Document

@article{65585b5be92e47e291a003cad777afeb,

title = "Heart Failure Therapy in Patients with Diabetes The new Benefit-Risk-Assessment of Sacubitril/Valsartan",

author = "Brandenburg, {Vincent Matthias} and {Brunner-La Rocca}, Hanspeter and Nikolaus Marx",

year = "2016",

month = oct,

doi = "10.1055/s-0042-000001",

language = "English",

volume = "141",

pages = "1647--1649",

journal = "Deutsche Medizinische Wochenschrift",

issn = "0012-0472",

publisher = "Georg Thieme Verlag",

number = "22",

}

TY - JOUR

T1 - Heart Failure Therapy in Patients with Diabetes The new Benefit-Risk-Assessment of Sacubitril/Valsartan

AU - Brandenburg, Vincent Matthias

AU - Brunner-La Rocca, Hanspeter

AU - Marx, Nikolaus

PY - 2016/10

Y1 - 2016/10

U2 - 10.1055/s-0042-000001

DO - 10.1055/s-0042-000001

M3 - Article

C2 - 27824422

VL - 141

SP - 1647

EP - 1649

JO - Deutsche Medizinische Wochenschrift

JF - Deutsche Medizinische Wochenschrift

SN - 0012-0472

IS - 22

ER -